Effect of Adherence with Clinical Outcomes and Quality of Life Primary Hypertension Patients in Pharmacy

Dumartina Hutauruk; Khairunnisa; Wiryanto

doi:10.32734/idjpcr.v3i2.5129

Authors

Dumartina Hutauruk Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
Khairunnisa Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
Wiryanto Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.32734/idjpcr.v3i2.5129

Keywords:

Adherence, Hypertension, Pharmacy, Quality of life.

Abstract

This study aimed to examine the effect of adherence to clinical outcomes and the quality of life of primary hypertension patients in pharmacy. The studywas conducted cross sectionally involved 60 patients at one of the pharmacies in Medan, Indonesia. Adherence was obtained in the form of adherence levels measured using the MMAS-8 questionnaire, clinical outcomes assessed by measuring a patient's blood pressure, and quality of life assessed using the EQ-5D-3L questionnaire. Then the data were analyzed using the Spearmen rho test. Patients who participated in the study consisted of 24 men and 36 women. Almost patient has low adherence with blood pressure mean of 156/ 90 mmHg. The patient's quality of life was 77.7%. Adherence has a significant relationship to clinical outcomes (p<0.05) with a strong correlation of r= -0.745. Adherence has a relationship to quality of life (p<0.05) with moderate correlation r= 0.554. This study concluded that adherence has a correlation with clinical outcomes and the quality of life of primary hypertension patients.

Downloads

Download data is not yet available.

References

Ministry of health of Indonesia. Indonesia health profile 2016. Jakarta: Data and Information Center of the Health Ministry of Republic of Indonesia, 2017. 102p.

WHO. Global Status Report on Noncommunicable Diseases. Switzerland: WHO, 2014. xiv p.

PERKI. Guidelines for management of dyslipidemia. Jakarta: Centra Communications, 2017. 10-14 p.

Ministry of health of Indonesia. Health Research 2018, Jakarta: Health Ministry of Republic of Indonesia, 2018. 156-160 p.

M.T. Brown, J. Brussell, S. Dutta, K. Davis, S. Strong, S. Mathew. “Medication Adherence: Truth and Consequences,” The American Journal of the Medical Sciences, vol. 351, no. 4, pp. 387-399. 2016.

A.P.F. Maciel, H.B. Pimenta, A.P. Caldeira. “Quality of life and medication adherence in hypertensive patients,” Acta Paul Enferm, vol. 29, no. 5, pp. 542-548. 2016.

C.D. Barbosa, M.M. Balp, K. Kulich, N. Germain, D. Rofail. “A Literature Review to Explore the Link between Treatment Satisfaction and Adherence, Complience, and Persistence.” Patient Preference and Adherence, vol. 6, pp. 39-48. 2012.

G.U. Iloh, A.N. Amadi. “Treatment Satisfaction, Medication Adherence, and Blood Pressure Control among Adult Nigerians with Essential Hypertension,” International Journal of Health & Allied Sciences, vol. 6, no. 2, pp. 75-81. 2017.

H. G.S. Femida, E. Manias, L. Lal, M. Salas, D.A. Hughes, A. R. Leewing, M. Grubisic. “Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group,” Value Health, vol. 16, no. 5, pp. 863-871. 2013.

O. Amaral, C. Chaves, J. Duarte, E. Countinho, P. Nelas, O. Preto. “Treatment Adherence in Hypertensive Patients-A Cross-sectional Study,” Sociall and Behavioral Sciences, vol. 171, pp. 1288-1295. 2014.

M. Burnier. “Drug Adherence in Hypertension,” Pharmacological Research., vol. 125, pp. 142-149. 2017.

S. Boratas, H.F. Kilic. “Evaluation of Medication Adherence in Hypertensive Patients and Influential Factors,” Pakistan Journal of Medical Sciences. Vol. 34, no. 4, pp. 1-5. 2018.

B. Uchmanowicz, A. Chudiak, G. Mazur. “The influence of quallity of life on the level of adherence to therapeutic recommendations among elderly hypertensive patients”, Patient Preference and Adherence, vol. 12, pp. 2593-2603. 2018.

M. Amer, N. U. Rahman, S.U.R. Nazir, A. Raza, H. Riaz, M. Sultana, S. Sadeeqa. “Impact of Pharmacist’s Intervention on Disease Related Knowledge, Medication Adherence, HRQoL and Control of Blood Pressure Among Hypertensive Patients,” Pak. J. Pharm. Sci, vol. 31, no. 6, pp. 2607-2616. 2018.

Q. Yao, C. Liu, Y. Zhang, L, Xu. “Health-Related Quality of Life of People with Self-Reported Hypertension: A National Cross-Sectional Survey in China,” International Journal of Environment Research and Public Health, vol. 16, no. 72, pp. 1-24. 2019.

D.A. Riani, Z. Ikawati, S.A. Kristina. “Validasi 8-item Morisky Medication Adherence Scale versi Indonesia pada pasien hipertensi dewasa di puskesmas kabupaten Sleman dan kota Yogyakarta,” Tesis, Universitas Gadjah Mada, 2017.

EuroQol Research Foundation. EQ-5D-3L User Guide. Basic Information on How to Use the EQ-5D-3L Instrument. Netherlands: Euroqol. 2018; 7-14 p.

K. Peltzer, S. Pengpid. “The prevalence and social determinants of hypertension among adults in Indonesia: a cross-sectional population-based national survey,” International Journal of Hypertension, pp.1-9. 2018.

B. Everett, A. Zajacova. “Gender differences in hypertension and hypertension awareness among young adult,” Biodemography Soc. Biol, vol. 61, no. 1, pp. 1-17. 2015.

S.S.B.E. Silva, S.F.S.B. Oliveira, A.M.G. Pierin. “The control of hypertension in men and women: a comparative analysis,” Journal of School of Nursing USP, vol. 5, no. 1, pp.50-58. 2016.

H.S. Mekonnen, M.H. Gebrie, K.H. Eyasu, A.A. Gelagay. “Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia,” BMC Pharmacology and Toxicology, vol. 18, no. 27, pp. 1-10. 2017.

A.A. Moura, S. Godoy, C.B. Cesarino, I.A.C. Mendes. “Factor determinig non-adherence to hypertension treatment,” Enfermerfe Global, pp. 27-39. 2016.

M. Burnier, B.M. Egan. “Adherence in Hypertension, A Review of Prevalence, Risk Factors, Impact, and Management,” AHAjournal, pp.1124-1140. 2019.

M. Mollaoglu, G. Solmaz, M. Mollaoglu. “Adherence to therapy and quality of life in hypertensive patients,” Acta Clin Croat, vol. 54, pp.438-444. 2015.

A.C.C. Souza, J.W.P. Borges, T.M.M. Moreira. “Quality of Life and Treatment Adherence in Hyertensive Patientss: systematic review with meta-analysisis,”Revista de Saude Publica, vol. 50, no. 71, p. pp. 1-14. 2016.

S.H. Zyoud, W. Al-Jabi, W.M. Sweileh, A.H. Wildali, H.M. Saleem, H.A. Aysa, M.A. Badwan, R. Awang, D.E. Morisky. “Health-related Quality of Life Associated with Treatment Adherence in Patients with Hypertension: A Cross-Sectional Study,” International Journal of Cardiology, vol. 168, no. 3, pp. 2981-2983. 2013.

E.W. Holt, P. Muntner, C.J. Joyce, L. Webber, M.A.K. Wood. “Health-related Quality of Life and Antihypertensive Medication Adherence among Older Adults,” Age and Ageing, vol. 39, pp. 481-487. 2010.